Global Parathyroid Hormone Market 2024 , Forecast To 2033
7 Mar, 2024
The parathyroid hormone market (6) has shown steady growth, set to increase from $2.35 billion in 2023 to $2.43 billion in 2024 at a CAGR of 3.5%, attributed to factors like rising prevalence of chronic kidney disease and increasing awareness of related disorders. Looking forward, the market is projected to see steady growth, reaching $3.5 billion in 2028 at a CAGR of 9.6%, driven by factors such as growing geriatric population and expanding healthcare access, with trends like advances in testing and drug delivery shaping its trajectory.
Global Parathyroid Hormone Market Key Driver
The prevalence of osteoporosis is driving the market for parathyroid hormones (6). With approximately 1.4 million Canadians affected, mainly postmenopausal women and the elderly, the use of parathyroid hormones to reduce fracture risk is increasing, thus contributing to market growth.
Get A Free Sample Of The Global Parathyroid Hormone Market ReportGlobal Parathyroid Hormone Market Segments
The parathyroid hormone market covered in this report is segmented –
1) By Disease Type: Hypocalcaemia, Hypoparathyroidism
2) By Product Type: Recombinant Parathtyoid Hormone, Parathyroid Hormone Analogues
3) By End-User: Hospitals, Clinics, Othe End-Users
By Geography: The countries covered in the parathyroid hormone market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
North America was the largest region in the parathyroid hormone market in 2023. The Middle East is expected to be the fastest-growing region in the global parathyroid hormone market share during the forecast period. The regions covered in the parathyroid hormone market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Major Parathyroid Hormone Industry Players
Pfizer Inc.; Eli Lilly and Company; Radius Health Inc.; Shire plc; Ascendis Pharma; Entera Bio Ltd.; Extend Biosciences Inc.; Gedeon Richter Plc.; Abbott Laboratories; Amgen Inc.; Merck & Co. Inc.; Novartis AG; F. Hoffmann-La Roche AG; Teva Pharmaceutical Industries Ltd.; Alcon Laboratories Inc.; Bayer Healthcare; Becton Dickinson and Company; Ethicon Inc.; Genentech Inc.; Medtronic Inc.; Mylan Laboratories; Novo Nordisk; Smith & Nephew plc; Stryker Corporation; Zimmer Biomet Holdings Inc.
Get The Full Global Parathyroid Hormone Market Report
Parathyroid Hormone Market Overview
Parathyroid hormone refers to a substance produced by the parathyroid gland that aids in the body's storage and utilization of calcium. High blood calcium levels are a result of parathyroid hormone levels that are greater than usual and could be a disease indicator. It is also known as PTH, parathyrin, and parathormone.